MedTrace Logo

Multiparametric Protocol for Assessment of Intraprocedural Result of MITRACLIP Procedure

NCT06184789 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-12-28

No results posted yet for this study

Summary

Quantification of residual mitral regurgitation (MR) after MitraClip may be challenging. Quantitative methods for severity assessment may be inaccurate and recent recommendations suggest an assessment of changes in both hemodynamic and echocardiographic parameters, but an established prospectively validated approach is still lacking.

Conditions

  • Residual Mitral Regurgitation

Interventions

DIAGNOSTIC_TEST

Echocardiographic assessment

Echocardiographic and hemodynamics assessment of Mitraclip results

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-27
Primary Completion
2020-04-30
Completion
2025-12-31
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06184789 on ClinicalTrials.gov